SKI Market

Indian Indices

Sensex

81,287.19 -961.42
( -1.17%)

Global Indices

Nasdaq

48,844.08 -676.12
(-1.37%)

Dow Jones

6,870.91 -58.95
(-0.85%)

Hang Seng

58,843.60 90.21
(0.15%)

Nikkei 225

10,926.32 79.62
(0.73%)

Forex

USD-INR

90.93 0.01
(0.01%)

EUR-INR

107.33 0.10
(0.10%)

GBP-INR

122.97 -0.01
(-0.01%)

JPY-INR

0.58 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Kopran Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524280

INE082A01010

86.2115334

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

KOPRAN

31.38

634.96

EPS(TTM)

Face Value()

Div & Yield %

4.19

2.28

Back

Ugro Capital standalone net profit declines 82.99% in the December 2025 quarter

Feb 07,2026

Net profit of Ugro Capital declined 82.99% to Rs 6.38 crore in the quarter ended December 2025 as against Rs 37.51 crore during the previous quarter ended December 2024. Sales rose 10.17% to Rs 408.88 crore in the quarter ended December 2025 as against Rs 371.12 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	408.88	371.12	10
OPM %	54.00	58.99	-
PBDT	23.68	65.46	-64
PBT	9.69	52.97	-82
NP	6.38	37.51	-83

81,287.19 -961.42 ( -1.17%)

48,844.08 -676.12 (-1.37%)

6,870.91 -58.95 (-0.85%)

58,843.60 90.21 (0.15%)

10,926.32 79.62 (0.73%)

90.93 0.01 (0.01%)

107.33 0.10 (0.10%)

122.97 -0.01 (-0.01%)

0.58 0.00 (0.12%)